SCHEMBL4944017

SCHEMBL4944017

O=c1ccc2ccc(Oc3cccc(CO)c3)cc2o1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.60
RAB9A P51151 1/20 0.60
CA12 O43570 6/20 0.57
CA9 Q16790 6/20 0.57
CA1 P00915 4/20 0.57
CA4 P22748 4/20 0.57
CA6 P23280 4/20 0.57
CA7 P43166 4/20 0.57
CA14 Q9ULX7 4/20 0.57
CA3 P07451 3/20 0.57
KMT2A Q03164 3/20 0.57
CA2 P00918 2/20 0.57
MAOB P27338 2/20 0.57
MEN1 O00255 2/20 0.57
MAOA P21397 1/20 0.57
MTNR1A P48039 1/20 0.57
CA5A P35218 3/20 0.54
CA5B Q9Y2D0 2/20 0.54
KDM4E B2RXH2 5/20 0.51
ALDH1A1 P00352 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6542961 0.82 CA12 (0.72) NPC1CA12CA9CA1CA4
SCHEMBL14802536 0.81 CA12 (0.63) NPC1CA12CA9CA1CA4
SCHEMBL3326190 0.78 CA12 (0.77) NPC1RAB9ACA12CA9CA1
SCHEMBL29603488 0.78 CA12 (0.77) NPC1RAB9ACA12CA9CA1
SCHEMBL14802648 0.78 CA12 (0.59) NPC1RAB9ACA12CA9CA1
SCHEMBL14634517 0.74 CA12 (0.77) NPC1RAB9ACA12CA9CA1
SCHEMBL13376996 0.73 CA12 (0.60) NPC1CA12CA9CA1CA4
SCHEMBL14802647 0.73 GBA1 (0.65) NPC1RAB9ACA12CA9CA1
7-Benzyloxycoumarin SCHEMBL29365449 0.72 MAOB (1.00) NPC1RAB9ACA12CA9CA1
7-Benzyloxycoumarin SCHEMBL3901170 0.72 MAOB (1.00) NPC1RAB9ACA12CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080293684-A1 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors MERCK SHARP & DOHME CORP. 2008-11-27 US disclosed
EP-1773774-A2 HETEROCYCLIC ACETOPHENONE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS Merck & Co., Inc. (US) 2007-04-18 EP disclosed
WO-2006014918-A2 HETEROCYCLIC ACETOPHENONE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERCK & CO., INC. (US) 2006-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293684-A1 Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors GRM2, GRM1, GRIK2 NPC1 2147/4885RAB9A 3449/4885CA12 3298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.